Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 650 clinical trials
Ivermectin and Doxycycine in COVID-19 Treatment

Efficacy of Ivermectin and Doxycycline in COVID-19 treatment

chloroquine
doxycycline
ivermectin
covid-19
  • 0 views
  • 16 Feb, 2024
  • 1 location
Tofacitinib for Treatment of Moderate COVID-19

The purpose of this randomized, double blinded, placebo controlled study is to assess the efficacy and safety of tofacitinib in hospitalized adult (18-65 years old) patients with SARS-CoV-2 and pneumonia who require supplemental oxygen and have serologic markers of inflammation but do not need mechanical ventilation.

acute respiratory syndrome (sars)
chest ct
coronavirus infection
SARS
hs-crp
  • 0 views
  • 05 Aug, 2020
Low Dose Radiotherapy for COVID-19 Pneumonitis

SARS-CoV-2 is causing an unprecedented stress on healthcare systems around the world, due to its high rate of infection and the high morbidity and mortality. The COVID-19 infection triggers an inflammatory cascade with cytokine synthesis, prompting the immune response. Low dose radiotherapy (LD-RT) ( 100 cGy) induces an anti-inflammatory response, …

acute respiratory syndrome (sars)
FIO2
chest ct
SARS
inflammatory response
  • 0 views
  • 05 Aug, 2020
Convalescent Plasma for the Treatment of COVID-19

This protocol provides access to investigational convalescent plasma for patients in acute care facilities infected with SARS-CoV-2 who have severe or life-threatening COVID-19, or who are judged by a healthcare provider to be at high risk of progression to severe or life-threatening disease. Following provision of informed consent, patients will …

acute respiratory syndrome (sars)
FIO2
shock
SARS
fraction of inspired oxygen (fio2)
  • 0 views
  • 16 Feb, 2024
  • 1 location
Hemostasis in COVID-19: an Adaptive Clinical Trial

Hypercoagulability has been demonstrated in COVID-19, leading to respiratory distress and increased mortality. This is adaptive clinical trial to compare effectiveness and safety of four therapeutic strategies in hospital mortality in patients with COVID-19: standard prophylaxis, therapeutic dose anticoagulation, inhaled UFH associated with standard prophylaxis and ASA associated with standard …

respiratory distress
enoxaparin
hypercoagulability
covid-19
thrombophilia
  • 0 views
  • 16 Feb, 2024
  • 1 location
HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists

The goal of this study is to understand the infectious exposure of SARS-coronavirus 2 (SARS-CoV2) among surgeons and anesthesiologists and to correlate this status with self-reported indices of COVID-19 illness.

acute respiratory syndrome (sars)
covid-19
coronavirus infection
SARS
antibody test
  • 0 views
  • 16 Feb, 2024
  • 1 location
COVID-19 Convalescent Plasma for Mechanically Ventilated Population

The purpose of this study is to see if this plasma can be safely used in humans with COVID-19 and to see if it can improve patients' health when they are sick with COVID-19.

acute respiratory syndrome (sars)
SARS
covid-19
mechanical ventilation
pneumonia
  • 0 views
  • 16 Feb, 2024
  • 1 location
Study of COVID-19 DNA Vaccine (AG0301-COVID19)

This study will assess the safety and immunogenicity of AG0301-COVID19 in healthy adult volunteers.

acute respiratory syndrome (sars)
covid-19
SARS
antibody test
dna vaccine
  • 0 views
  • 05 Aug, 2020
Colchicine Plus Phenolic Monoterpenes to Treat COVID-19

In this study, defined cases of COVID-19 with mild, moderate or severe pneumonia will be treated with standard treatment regimens in combination with oral administration of Colchicine Plus Herbal phenolic monoterpene Fractions.

covid-19
pneumonia
colchicine
  • 0 views
  • 05 Aug, 2020
Immunity and Safety of Covid-19 Synthetic Minigene Vaccine

In December 2019, viral pneumonia caused by a novel beta-coronavirus (Covid-19) broke out in Wuhan, China. Some patients rapidly progressed and suffered severe acute respiratory failure and died, making it imperative to develop a safe and effective vaccine to treat and prevent severe Covid-19 pneumonia.

  • 0 views
  • 16 Feb, 2024
  • 3 locations